chr11-110430242-G-C
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_004109.5(FDX1):āc.122G>Cā(p.Arg41Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000756 in 1,205,422 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_004109.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FDX1 | NM_004109.5 | c.122G>C | p.Arg41Pro | missense_variant | 1/4 | ENST00000260270.3 | NP_004100.1 | |
FDX1 | XM_047426566.1 | c.8+889G>C | intron_variant | XP_047282522.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FDX1 | ENST00000260270.3 | c.122G>C | p.Arg41Pro | missense_variant | 1/4 | 1 | NM_004109.5 | ENSP00000260270 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000555 AC: 84AN: 151416Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.000785 AC: 827AN: 1053898Hom.: 4 Cov.: 30 AF XY: 0.000780 AC XY: 388AN XY: 497542
GnomAD4 genome AF: 0.000554 AC: 84AN: 151524Hom.: 0 Cov.: 32 AF XY: 0.000594 AC XY: 44AN XY: 74052
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 10, 2021 | The c.122G>C (p.R41P) alteration is located in exon 1 (coding exon 1) of the FDX1 gene. This alteration results from a G to C substitution at nucleotide position 122, causing the arginine (R) at amino acid position 41 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at